Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Fate Therapeutics, Inc. et al v. Shoreline Biosciences, Inc. et al
Case Number:
3:22-cv-00676
Court:
Nature of Suit:
Judge:
Firms
- Crowell & Moring
- Duane Morris
- Gibson Dunn
- Goodwin Procter
- Greenberg Traurig
- Hooper Lundy
- Morrison & Foerster
- Wilson Turner Kosmo
- Wright L'Estrange
Companies
Sectors & Industries:
-
October 17, 2023
Stem Cell Research Biz Loses $7M Atty Fee Bid In Patent Fight
A California federal judge has denied a stem cell research startup's bid for a $7 million attorney fee award after successfully defeating a rival's patent infringement suit, saying the dispute was a "run-of-the-mill patent case" that doesn't warrant awarding fees to the prevailing party.
-
September 01, 2023
Gilead-Backed Stem Cell Startup Beats Patent Suit
A stem cell research startup funded by Gilead Sciences has beaten a suit from an MIT-backed rival alleging the startup infringed patents covering a stem cell process developed by a top professor at the school.